Insider · CIK 0001846478

Gutwerg Ori

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001846478

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−3,162 sh	$77.00	−$243K	75,534
2026-05-12	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−2,772 sh	$79.50	−$220K	78,696
2026-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−3,314 sh	$74.04	−$245K	81,468
2026-03-03	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−2,060 sh	$76.50	−$158K	84,782
2026-02-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−2,221 sh	$73.90	−$164K	86,842
2026-02-26	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+13K sh	$77.15	+$1M	89,063
2026-02-14	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,888 sh	$77.36	−$146K	76,094
2026-02-12	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,775 sh	$76.70	−$136K	77,982
2026-02-11	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−4,267 sh	$76.25	−$325K	79,757
2025-08-12	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−5,873 sh	$86.53	−$508K	84,024
2025-05-15	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−881 sh	$60.07	−$52.9K	89,897
2025-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−3,314 sh	$60.62	−$201K	90,778
2025-03-05	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP, GENERICS	MExercise/Conversion	+300 sh	$31.49	+$9,447	99,476
2025-03-05	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	SVP, GENERICS	MExercise/Conversion	−300 sh	$31.49	−$9,447	13,204
2025-03-05	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−5,084 sh	$60.00	−$305K	94,092
2025-03-05	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−300 sh	$60.03	−$18K	99,176
2025-02-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,570 sh	$61.89	−$97.2K	99,176
2025-02-15	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,167 sh	$58.92	−$68.8K	100,746
2025-02-14	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,426 sh	$58.92	−$84K	101,913
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+15.7K sh	—	—	92,895
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+10.4K sh	—	—	103,339
2024-06-05	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−2,985 sh	$67.00	−$200K	77,227
2024-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−2,494 sh	$66.71	−$166K	80,212
2024-02-29	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,570 sh	$67.67	−$106K	82,706
2024-02-15	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,244 sh	$57.55	−$71.6K	84,276
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+14.8K sh	—	—	75,678
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+9,842 sh	—	—	85,520
2023-08-23	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	SVP, GENERICS	MExercise/Conversion	+13.5K sh	$31.49	+$425K	76,476
2023-08-23	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−2,059 sh	$62.39	−$128K	60,915
2023-08-23	ANIPANI PHARMACEUTICALS INCS Sale	SVP, GENERICS	SSale	−13.5K sh	$62.39	−$842K	62,974
2023-08-23	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	SVP, GENERICS	MExercise/Conversion	−13.5K sh	$31.49	−$425K	13,504
2023-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,756 sh	$44.23	−$77.7K	34,613
2023-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−586 sh	$44.23	−$25.9K	34,027
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+11.6K sh	—	—	62,974
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+17.4K sh	—	—	51,396
2023-02-15	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,275 sh	$45.04	−$57.4K	36,369
2022-04-27	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+6,476 sh	—	—	37,644
2022-03-24	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+19.4K sh	—	—	31,168
2022-02-15	ANIPANI PHARMACEUTICALS INCF Tax Payment	SVP, GENERICS	FTax Payment	−1,167 sh	$40.25	−$47K	11,740
2021-02-15	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)A Award	SVP, GENERICS	AAward	+27K sh	—	—	27,006
2021-02-15	ANIPANI PHARMACEUTICALS INCA Award	SVP, GENERICS	AAward	+12.9K sh	—	—	12,907

Recent filings

Accepted (ET)
Aug 114
Gutwerg Ori0001846478-26-000015
SEC(opens sec.gov)
May 134
Gutwerg Ori0001846478-26-000013
SEC(opens sec.gov)
Mar 104
Gutwerg Ori0001846478-26-000010
SEC(opens sec.gov)
Mar 44
Gutwerg Ori0001846478-26-000008
SEC(opens sec.gov)
Mar 24
Gutwerg Ori0001846478-26-000006
SEC(opens sec.gov)
Feb 174
Gutwerg Ori0001846478-26-000004
SEC(opens sec.gov)
Feb 134
Gutwerg Ori0001846478-26-000002
SEC(opens sec.gov)
Aug 144
Gutwerg Ori0001846478-25-000013
SEC(opens sec.gov)
May 164
Gutwerg Ori0001846478-25-000011
SEC(opens sec.gov)
Mar 144
Gutwerg Ori0001846478-25-000009
SEC(opens sec.gov)
Mar 74
Gutwerg Ori0001846478-25-000007
SEC(opens sec.gov)
Mar 44
Gutwerg Ori0001846478-25-000005
SEC(opens sec.gov)
Feb 184
Gutwerg Ori0001846478-25-000003
SEC(opens sec.gov)

Companies

ANI PHARMACEUTICALS INCSVP, GENERICSANIP

Address

C/O ANI PHARMACEUTICALS, INC. 104 CARNEGIE CENTER, SUITE 300

PRINCETON, NJ, 08540